VPI-2690B
Gecertificeerd

VPI-2690B

Catalog #: HY-P991254
Maat: 1 Each

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

VPI-2690B is a human monoclonal antibody (mAb) targeting Integrin aVb3. VPI-2690B inhibits TGF-β signaling. VPI-2690B can be used in Diabetic nephropathies research[1].

UNSPSC

12352203

Target

Integrin; TGF-β Receptor

Related Pathways

Cytoskeleton; TGF-beta/Smad

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Smiles

[VPI-2690B]

References & Citations

[1]Park CH, et al. TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. Pharmaceuticals (Basel) . 2022 Nov 29;15 (12) :1485.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P991254/

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Beschrijving

VPI-2690B is a human monoclonal antibody (mAb) targeting Integrin aVb3. VPI-2690B inhibits TGF-β signaling. VPI-2690B can be used in Diabetic nephropathies rese

Specificaties

ProductnaamVPI-2690B
Categorie
Beschikbare grootte1 Each
CatalogusnummerHY-P991254